Aspen Aerogels, Inc. Reports First Quarter 2024 Financial Results and Recent Business Highlights

$94.5 million in company revenue drove 37% gross profit margins and $12.9 million of Adjusted EBITDA
Raising 2024 baseline Adjusted EBITDA outlook by 83%
Expecting positive net income for 2024

NORTHBOROUGH, Mass., May 1, 2024 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the first quarter of 2024, and discussed recent business developments.

Total revenue for the first quarter of 2024 was $94.5 million, compared to $45.6 million in the first quarter of 2023. Net loss was $1.8 million, compared to a net loss of $16.8 million in the first quarter of 2023. Net loss per share was $0.02, compared to a net loss per share of $0.24 in the first quarter of 2023.

Adjusted EBITDA for the first quarter of 2024 was $12.9 million, compared to $(13.9) million in the first quarter of 2023. A reconciliation of net loss to non-GAAP Adjusted EBITDA is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

Recent Business Highlights & Quarterly Performance

    --  Company revenue of $94.5 million, up 12% quarter-over-quarter (QoQ) and
        107% year-over-year (YoY)
        --  Thermal Barriers: $65.4 million of revenue, up 23% QoQ and 459% YoY
        --  Energy Industrial: $29.1 million of supply constrained revenue, down
            7% QoQ and down 14% YoY
    --  Energy Industrial segment on path to deliver over $150 million of
        revenue in 2024, shipped $14.6 million of revenue from our external
        manufacturing facility in Q1
    --  Delivered gross margins of 37%, a 2-percentage point improvement QoQ and
        26-percentage point improvement YoY
    --  Adjusted EBITDA of $12.9 million, a $3.8 million improvement or 42% QoQ
        and $26.9 million improvement YoY
    --  Operating income of $2.4 million, a $1.1 million improvement or 76% QoQ
        and $21.3 million improvement YoY
    --  Ended first quarter of 2024 with cash and equivalents of $101.5 million
    --  Received coveted Automotive News PACE Award for PyroThin(®)
        cell-to-cell (C2C) barrier platform; Automotive News' PACE program is
        recognized globally as the most prestigious innovation award for
        automotive suppliers
    --  Also presented with a PACE Innovation Partnership Award, recognizing
        Aspen's collaboration with General Motors centered on our PyroThin C2C
        barriers as the thermal runaway solution for GM's Ultium battery
        platform

"We continue to execute the transition of our Energy Industrial products to our external manufacturing facility and dedicate our manufacturing plant in East Providence to the production of aerogel for EV thermal barriers. We believe the Q1 results further demonstrate that we have the capability with existing assets and supply arrangements to deliver $650 million of annual revenue with at least 35% gross margins and 25% Adjusted EBITDA margins," commented Don Young, Aspen's President and CEO. "We remain deeply engaged with a growing list of automotive OEMs and battery cell manufacturers and have strong conviction that we are providing a unique solution to a very challenging problem. We remain focused on scaling the five OEM awards that we have in hand alongside maximizing our Energy Industrial business."

Updated 2024 Financial Outlook
Aspen updated its 2024 full year outlook as follows:



     
       ($ in millions, except per share amounts)


       
     
              Metric                              Prior 2024
                                                          Outlook      Updated 2024 Outlook Delta % Improvement



     
       Revenue                               
         >350          
         >380                 30             9%

                         YoY Growth                            47%                      59%   12%           26%


          Adjusted EBITDA                        
         >30          
         >55                  25           83 %


          Net Income (Loss)                     
         >(23)          
         >2                  25          109 %


          Earnings Per Share                  
         >(0.30)        
         >0.03               0.33          109 %

The Company's 2024 outlook assumes depreciation and amortization of $30 million, stock-based compensation expense of $14 million, other (income) expense and income tax expense of $9 million, and weighted average shares outstanding of 75.8 million for the full year.

A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2024 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

Ricardo C. Rodriguez, Chief Financial Officer and Treasurer noted, "We added $10 million of revenue quarter over quarter, a 12% increase. More importantly, we increased Adjusted EBITDA by 42% quarter over quarter, to $12.9 million, and operating income increased by 76%, further validating the scalability of our operations. We are increasingly optimistic about our outlook for the year as our main automotive OEM customers capture their fair share of the EV market, and our Energy Industrial customers benefit from incremental supply through our external manufacturing facility." Mr. Rodriguez added, "These elements, combined with our team's continued execution, enable us to raise our 2024 baseline Adjusted EBITDA outlook by 83%, to $55 million on $380 million of revenue, and to anticipate positive net income for the year."

Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2024, including those related to the planned capacity expansion, supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

Last Twelve-Month Financial Comparison
A comparison of key financial metrics for the trailing twelve-month periods ended March 31, 2023 and 2024:



     
     ($ in millions)


                 Metric         LTM Q1 2023 LTM Q1 2024  Delta   % Improvement


        Revenue                         188          288     100             53 %


        Gross Profit                     12           87      75            629 %

                       % Margin          6%         30%


        Adjusted EBITDA                (60)           4      64            107 %

                       % Margin       (32%)          1%


        Operating Income               (80)        (28)     52             65 %

                       % Margin       (42%)       (10%)


        Net Loss                       (80)        (31)     49             61 %

                       % Margin       (43%)       (11%)


        Total CAPEX                     213          152    (61)            29 %

Conference Call and Webcast Notification
A conference call with Aspen management to discuss first quarter 2024 results and recent business developments will be held Thursday, May 2, 2024 at 8:30 a.m. ET. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

Shareholders and other interested parties may call +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "917527" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.

Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.

Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides an additional financial metric that is not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measure does not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

Management believes that this non-GAAP financial measure reflects Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that this non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. This non-GAAP measure may not be comparable to similarly titled measures presented by other companies.

The non-GAAP financial measure does not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.

About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility, and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. Aspen Battery Materials, the Company's carbon aerogel initiative, seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of EVs. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2024 financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's 2024 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about higher than expected demand from the EV market and how it may enable a path to profitability, expectations about improvement in ability to absorb fixed costs and reduction of conversion costs as a percentage of sales and the same leading to target revenue capacity and gross margins and Adjusted EBITDA margins; Aspen's expectations regarding the planned second manufacturing plant in Georgia ("Plant II"), the extended construction and commissioning timeframe for Plant II, Aspen's efforts to manage the construction of Plant II to align with our expectations of demand from EV customers, and the use of contract manufacturers to meet demand from Energy Industrial customers; beliefs about the general strength, weakness or health of Aspen's business; acceleration in demand; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the electric vehicle market; beliefs about Aspen's ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's electric vehicle opportunities, including the EV thermal barrier business; beliefs about revenue growth and profitability; beliefs about the performance of PyroThin(®) including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen's ability to expand the market for PyroThin(®), to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen's thermal barrier design, prototype, quoting and assembly activities; and expectations about the cost of the capital projects, including Plant II; and beliefs about the Company's pending application with the DOE seeking a loan pursuant to the DOE LPO's ATVM. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to execute the growth plan, inability to continue construction of Plant II and to do so at a cost consistent with Aspen's estimates and aligned with Aspen's expectations of demand from our EV customers; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen's inability to create customer or market opportunities for, including PyroThin(®); any other battery performance and safety products, battery materials or for other new products developed from Aspen's aerogel technology; any disruption or inability to achieve expected capacity levels in any of the three existing production lines in East Providence, RI or the Mexico assembly facility or at any contract manufacturer; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading "Risk Factors" in Aspen's Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the Securities and Exchange Commission ("SEC") on March 7, 2024, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.


                                                                
           
                ASPEN AEROGELS, INC.
                                                             
             Condensed Consolidated Balance Sheets
                                                                  
             (Unaudited and in thousands)






                                                                                                                        March 31,                      December 31,


                                                                                                                  2024                        2023


                                                                                                                              (In thousands)



     
                Assets



     Current assets:



     Cash and cash equivalents                                                                              $
      101,461                  $
       139,723



     Restricted cash                                                                                                157                           248



     Accounts receivable, net                                                                                    84,029                        69,995



     Inventories                                                                                                 45,750                        39,189



     Prepaid expenses and other current assets                                                                   23,708                        17,176



     Total current assets                                                                                       255,105                       266,331



     Property, plant and equipment, net                                                                         422,736                       417,227



     Operating lease right-of-use assets                                                                         16,824                        17,212



     Other long-term assets                                                                                       3,324                         2,278



     Total assets                                                                                           $
      697,989                  $
       703,048



     
                Liabilities and Stockholders' Equity



     Current liabilities:



     Accounts payable                                                                                        $
      44,713                   $
       51,094



     Accrued expenses                                                                                            12,762                        22,811



     Deferred revenue                                                                                             3,130                         2,316



     Finance obligation for sale and leaseback transactions                                                       1,206



     Operating lease liabilities                                                                                  1,769                         1,874



     Total current liabilities                                                                                   63,580                        78,095



     Convertible note - related party                                                                           118,030                       114,992



     Finance obligation for sale and leaseback transactions long-term                                             3,556



     Operating lease liabilities long-term                                                                       21,620                        21,906



     Total liabilities                                                                                          206,786                       214,993



     Stockholders' equity:



     Total stockholders' equity                                                                                 491,203                       488,055



     Total liabilities and stockholders' equity                                                             $
      697,989                  $
       703,048


                                                   
              
                ASPEN AEROGELS, INC.
                                                
                Consolidated Statements of Operations
                                    
                (Unaudited and in thousands, except share and per share data)




                                                                                                                               Three Months Ended


                                                                                                                                    March 31,


                                                                                                                     2024                             2023


                                                                                                                              (In thousands, except
                                                                                                               share and per share data)





     Revenue                                                                                               $
           94,501                   $
            45,586



     Cost of revenue                                                                                                59,358                             40,500



     Gross profit                                                                                                   35,143                              5,086



     Operating expenses:



     Research and development                                                                                        4,489                              4,099



     Sales and marketing                                                                                             8,303                              7,713



     General and administrative                                                                                     17,213                             12,182



     Impairment of equipment under development                                                                       2,702



     Total operating expenses                                                                                       32,707                             23,994



     Income (loss) from operations                                                                                   2,436                           (18,908)



     Other income (expense)



     Interest expense, convertible note - related party                                                            (3,038)                             (275)



     Interest income (expense)                                                                                       (477)                             2,387



     Total other income (expense)                                                                                  (3,515)                             2,112



     Loss before income tax expense                                                                                (1,079)                          (16,796)



     Income tax expense                                                                                              (756)



     Net loss                                                                                             $
           (1,835)                $
            (16,796)



     Net loss per share:



     Basic and diluted                                                                                     $
           (0.02)                  $
            (0.24)



     Weighted-average common shares outstanding:



     Basic and diluted                                                                                          75,762,893                         69,162,739

Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.


                                                                                 Three Months Ended


                                                                                 March 31, 2024


                                                                                 (In thousands)



     Net cash provided by (used in):



     Operating activities                                              $
      (17,749)



     Investing activities                                                  (25,863)



     Financing activities                                                     5,259



     Net (decrease) increase in cash                                       (38,353)



     Cash, cash equivalents and restricted cash at beginning of period      139,971



     Cash, cash equivalents and restricted cash at end of period        $
      101,618

Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:

Reconciliation of Adjusted EBITDA to Net Loss
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.

For the three months ended March 31, 2024 and 2023:


                                                Three Months Ended


                                                     March 31,


                                         2024                       2023


                                                  (In thousands)



     Net loss                      $
      (1,835)             $
         (16,796)



     Depreciation and amortization       5,786                        2,704



     Stock-based compensation            4,706                        2,267



     Other expense (income)              3,515                      (2,112)



     Income tax expense                    756



     Adjusted EBITDA                $
      12,928              $
         (13,937)

For the trailing twelve months ended March 31, 2024 and 2023:


                                                   Last Twelve Months


                                                       March 31,


                                            2024                       2023


                                                     (In thousands)



     Net loss                      $
        (30,850)             $
         (80,050)



     Depreciation and amortization         18,400                        9,797



     Stock-based compensation              13,393                        9,824



     Other expense                          2,235                          521



     Income tax expense                       756



     Adjusted EBITDA                  $
        3,934              $
         (59,908)

For the 2024 full year financial outlook:


                                                                  Year Ending


                                                               December 31, 2024


                                                           Current                        Prior


                                                                 (In thousands)



     Net income (loss)                          $
      2,000                 $
        (23,000)



     Depreciation and amortization                 30,000                         30,000



     Stock-based compensation                      14,000                         14,000



     Other expense, net and income tax expense      9,000                          9,000



     Adjusted EBITDA                           $
      55,000                   $
        30,000

View original content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-first-quarter-2024-financial-results-and-recent-business-highlights-302133691.html

SOURCE Aspen Aerogels, Inc.